Trinity Biotech plc (
) will begin trading ex-dividend on June 06, 2013. A cash dividend
payment of $0.2 per share is scheduled to be paid on July 01, 2013.
Shareholders who purchased TRIB stock prior to the ex-dividend date
are eligible for the cash dividend payment. This represents an
33.33% increase over the prior year.
The previous trading day's last sale of TRIB was $17.33,
representing a -8.79% decrease from the 52 week high of $19 and a
59.14% increase over the 52 week low of $10.89.
TRIB is a part of the Health Care sector, which includes
companies such as IDEXX Laboratories, Inc. (
) and Myriad Genetics, Inc. (
). TRIB's current earnings per share, an indicator of a company's
profitability, is $.77. Zacks Investment Research reports TRIB's
forecasted earnings growth in 2013 as 3.9%, compared to an industry
average of 8.8%.
For more information on the declaration, record and payment
dates, visit the